Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This term describes the inherent ability of pluripotent and some multipotent stem cells to differentiate into multiple distinct cell lineages—including osteogenic (bone), chondrogenic (cartilage), neurogenic (nerve), hepatocytic (liver), cardiomyocytic (heart muscle), and endothelial (vascular) cells—depending on cues from the cellular environment or directed induction protocols. The process is controlled by a complex interplay of transcription factors (e.g., OCT4, SOX2, NANOG for pluripotency) and multiple signaling pathways (e.g., Wnt, TGF-β, Notch)[1][2][3][9]. It is foundational for regenerative medicine and developmental biology, but not a molecular target in itself.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Differentiation into multiple lineages.